Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Zydus Lifesciences Limited Press Release Dec 11 2023

· Issued by Zydus Lifesciences Limited via NSE India

Filed with NSE · · 3 pages · English

Release

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 11, 2023, titled "Zydus andDaewoong Pharmaceutical announce exclusive licensing agreement for development andcommercialization of Leuprolide Long-Acting Injectable in the U.S.".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases